The paper seeks to prove the point that the Indian OTC derivatives markets, unlike many other jurisdictions, are well regulated. Only contracts where one party to the contract is an RBI regulated entity are considered legally valid in India. A good reporting system and a post-trade clearing and...

This paper highlights the status of the Indian biopharmaceutical industry and also makes a comparison with the global scenario. It also discusses the current situation regarding patenting biopharmaceuticals in India. [GIDR WP no. 168].